Position in PGEN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,676,895
-$282,874 QoQ
Shares Held
433,307
-7.6% QoQ
Ownership
0.122%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,063,863 across 270 Biotechnology names. PGEN ranks #142 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in PGEN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,676,895 | 433,307 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,959,769 | 468,845 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,255,525 | 381,619 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $464,864 | 327,370 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $494,591 | 331,942 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $367,221 | 327,878 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $317,252 | 333,952 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $666,422 | 421,788 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $583,603 | 402,487 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $598,176 | 446,401 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $646,437 | 455,238 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $497,603 | 432,700 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $402,347 | 379,574 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $508,563 | 334,582 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $713,033 | 336,337 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $421,426 | 314,498 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $672,226 | 318,591 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $1,248,457 | 336,512 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $1,716,049 | 343,898 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $2,066,591 | 316,962 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,075,948 | 301,299 | Shares | Defined | 2021-05-13 | |
| 2020-09-30 | $984,028 | 281,151 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,423,859 | 285,343 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,028,329 | 302,450 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||